Accès gratuit
Numéro
Med Sci (Paris)
Volume 24, Numéro 1, Janvier 2008
Page(s) 7 - 9
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20082417
Publié en ligne 15 janvier 2008
  1. Barre-Sinoussi F, Chermann JC, Rey M, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220 : 868–71. [Google Scholar]
  2. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384 : 529–34. [Google Scholar]
  3. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272 : 1167–70. [Google Scholar]
  4. Costagliola D, Downs AM. Incubation time for AIDS. Nature 1987; 328 : 582. [Google Scholar]
  5. Buchbinder SP, Katz MN, Hessol NA, et al. Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8 : 1123–8. [Google Scholar]
  6. Lambotte O, Boufassa F, Madec Y, et al. HIV controllers : a homogeneous group of HIV-1-infected patients with spontaneous cont rol of viral replication. Clin Infect Dis 2005; 41 : 1053–6. [Google Scholar]
  7. Cao Y, Qin L, Zhang L, et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332 : 201–8. [Google Scholar]
  8. Candotti D, Costagliola D, Joberty C, et al. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. J Med Virol 1999; 58 : 256–263. [Google Scholar]
  9. Magierowska M, Theodorou I, Debre P, et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1- infected individuals. Blood 1999; 93 : 936–41. [Google Scholar]
  10. Klein MR, van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection : a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995; 181 : 1365–72. [Google Scholar]
  11. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278 : 47–1450. [Google Scholar]
  12. Martinez V, Costagliola D, Bonduelle O, et al. Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. J Infect Dis 2005; 191 : 2053–63. [Google Scholar]
  13. Blankson JN, Bailey JR, Thayil S, et al. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol 2007; 81 : 2508–18. [Google Scholar]
  14. Lamine A, Caumont-Sarcos A, Chaix ML, et al. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 2007; 21 : 1043–5. [Google Scholar]
  15. Sajadi MM, Heredia A, Le N, et al. HIV-1 natural viral suppressors : control of viral replication in the absence of therapy. AIDS 2007; 21 : 517–9. [Google Scholar]
  16. Saez-Cirion A, Lacabaratz C, Lambotte M, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007; 104 : 6776–81. [Google Scholar]
  17. Emu B, Sinclair E, Favre D, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005; 79 : 14169–78. [Google Scholar]
  18. Addo MM, Draenert R, Rathod A, et al. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS One 2007; 2 : e321. [Google Scholar]
  19. Bailey JR, Williams TM, Siliciano RF, et al. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med 2006; 203 : 1357–69. [Google Scholar]
  20. Bailey JR, Lassen KG, Yang HC, et al. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J Virol 2006; 80 : 4758–70. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.